Asabys Partners, alongside Alta Life Sciences, BPI France, Fund+ and Ysios Capital Partners, have invested in a €30m series-A round for drug development company Ona Therapeutics.
Asabys Partners, alongside Alta Life Sciences, BPI France, Fund+ and Ysios Capital Partners, have invested in a €30m series-A round for drug development company Ona Therapeutics.